HCM II Acquisition Corp. (NASDAQ:HOND - Get Free Report) was up 8% on Thursday . The stock traded as high as $18.62 and last traded at $18.45. Approximately 814,274 shares traded hands during trading, an increase of 53% from the average daily volume of 531,351 shares. The stock had previously closed at $17.09.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of HCM II Acquisition in a research report on Wednesday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of "Sell".
Get Our Latest Report on HCM II Acquisition
HCM II Acquisition Trading Up 5.7%
The firm's 50-day simple moving average is $13.01 and its two-hundred day simple moving average is $11.74.
Hedge Funds Weigh In On HCM II Acquisition
Large investors have recently bought and sold shares of the stock. Calamos Advisors LLC purchased a new position in shares of HCM II Acquisition in the 1st quarter valued at $5,288,000. Context Capital Management LLC acquired a new position in shares of HCM II Acquisition in the 1st quarter valued at about $3,156,000. Mizuho Securities USA LLC acquired a new position in shares of HCM II Acquisition in the 1st quarter valued at about $271,000. MMCAP International Inc. SPC bought a new stake in HCM II Acquisition in the 1st quarter valued at about $10,310,000. Finally, Magnetar Financial LLC bought a new stake in HCM II Acquisition in the 1st quarter valued at about $20,719,000.
HCM II Acquisition Company Profile
(
Get Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.